Sorbitol, osmoregulation, and the complications of diabetes.
作者信息
Burg M B, Kador P F
机构信息
National Heart, Lung and Blood Institute, Bethesda, Maryland 20892.
出版信息
J Clin Invest. 1988 Mar;81(3):635-40. doi: 10.1172/JCI113366.
Abstract
摘要
相似文献
1
Sorbitol, osmoregulation, and the complications of diabetes.山梨醇、渗透调节与糖尿病并发症
J Clin Invest. 1988 Mar;81(3):635-40. doi: 10.1172/JCI113366.
2
Role of aldose reductase and sorbitol in maintaining the medullary intracellular milieu.醛糖还原酶和山梨醇在维持髓质细胞内环境中的作用。
Kidney Int. 1988 Mar;33(3):635-41. doi: 10.1038/ki.1988.46.
3
[Pathobiochemistry of the late-onset diabetic syndrome].[迟发性糖尿病综合征的病理生物化学]
Med Klin. 1974 Sep 6;69(36):1417-23.
4
Etiology of cataracts in diabetics.糖尿病患者白内障的病因
Int Ophthalmol Clin. 1984 Winter;24(4):93-110.
5
The diabetic cornea.糖尿病性角膜
Int Ophthalmol Clin. 1984 Winter;24(4):111-23.
6
Organic osmolytes in diabetes mellitus.糖尿病中的有机渗透溶质
Exp Nephrol. 1994 Jan-Feb;2(1):18-23.
7
[Sorbitol and its role in nutrition].[山梨醇及其在营养中的作用]
Vopr Pitan. 1983(1):3-5.
8
Molecular basis for osmoregulation of organic osmolytes in renal medullary cells.肾髓质细胞中有机渗透溶质渗透调节的分子基础。
J Exp Zool. 1994 Feb 1;268(2):171-5. doi: 10.1002/jez.1402680216.
9
Cellular osmoregulation in kidney medulla.肾髓质中的细胞渗透调节
Contrib Nephrol. 1998;123:169-84. doi: 10.1159/000059912.
引用本文的文献
1
Targeting pericyte retention in Diabetic Retinopathy: a review.靶向糖尿病视网膜病变中的周细胞保留：综述。
Ann Med. 2024 Dec;56(1):2398200. doi: 10.1080/07853890.2024.2398200. Epub 2024 Sep 13.
2
Gene expression in the dorsal root ganglion and the cerebrospinal fluid metabolome in polyneuropathy and opioid tolerance in rats.大鼠多发性神经病和阿片类药物耐受性中背根神经节的基因表达及脑脊液代谢组学
IBRO Neurosci Rep. 2024 May 24;17:38-51. doi: 10.1016/j.ibneur.2024.05.006. eCollection 2024 Dec.
3
HIF-1 inhibition reverses opacity in a rat model of galactose-induced cataract.低氧诱导因子-1 抑制逆转半乳糖诱导白内障大鼠模型的混浊。
PLoS One. 2024 Feb 28;19(2):e0299145. doi: 10.1371/journal.pone.0299145. eCollection 2024.
4
Glutamate is effective in decreasing opacity formed in galactose-induced cataract model.谷氨酸在降低半乳糖诱导的白内障模型中形成的晶状体混浊方面有效。
Sci Rep. 2024 Feb 19;14(1):4123. doi: 10.1038/s41598-024-54559-y.
5
In-silico molecular designs to treat neurologic and ophthalmologic diseases caused by sorbitol excess: engineering the Agrobacterium vitis protein.利用虚拟分子设计治疗山梨醇过量引起的神经和眼科疾病：工程化农杆菌 vitis 蛋白。
BMC Res Notes. 2023 Jul 3;16(1):129. doi: 10.1186/s13104-023-06367-2.
6
Erythritol synthesis is elevated in response to oxidative stress and regulated by the non-oxidative pentose phosphate pathway in A549 cells.在A549细胞中，赤藓糖醇的合成会因氧化应激而增加，并受非氧化磷酸戊糖途径调控。
Front Nutr. 2022 Oct 6;9:953056. doi: 10.3389/fnut.2022.953056. eCollection 2022.
7
Pathophysiology and Molecular Imaging of Diabetic Foot Infections.糖尿病足感染的病理生理学和分子影像学。
Int J Mol Sci. 2021 Oct 26;22(21):11552. doi: 10.3390/ijms222111552.
8
Dietary Diversification and Specialization in Neotropical Bats Facilitated by Early Molecular Evolution.饮食多样化和新热带蝙蝠的专业化是由早期分子进化促成的。
Mol Biol Evol. 2021 Aug 23;38(9):3864-3883. doi: 10.1093/molbev/msab028.
9
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病视网膜病变：对视力保护及未来展望的见解
Cardiovasc Endocrinol Metab. 2020 May 18;10(1):3-13. doi: 10.1097/XCE.0000000000000209. eCollection 2021 Mar.
10
Metabolomic Analysis of Infection in S2 Cells Reveals Divergent Effects on Central Carbon Metabolism as Compared with Silkworm Bm5 Cells.感染 S2 细胞的代谢组学分析显示，与家蚕 Bm5 细胞相比，其对中心碳代谢的影响存在差异。
Viruses. 2020 Apr 1;12(4):393. doi: 10.3390/v12040393.
本文引用的文献
1
Living with water stress: evolution of osmolyte systems.应对水分胁迫：渗透调节物质系统的进化
Science. 1982 Sep 24;217(4566):1214-22. doi: 10.1126/science.7112124.
2
Corneal re-epithelialization in galactosemic rats.半乳糖血症大鼠的角膜再上皮化
Invest Ophthalmol Vis Sci. 1983 May;24(5):563-9.
3
The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.醛糖还原酶抑制对糖尿病大鼠运动神经传导速度的影响。
Diabetes. 1982 Sep;31(9):789-94. doi: 10.2337/diab.31.9.789.
4
Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.醛糖还原酶抑制剂治疗糖尿病性多发性神经病的效果——一项临床及神经生理学研究
J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991-1001. doi: 10.1136/jnnp.44.11.991.
5
Corneal endothelial changes in type I and type II diabetes mellitus.I型和II型糖尿病患者的角膜内皮变化
Am J Ophthalmol. 1984 Oct 15;98(4):401-10. doi: 10.1016/0002-9394(84)90120-x.
6
Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.醛糖还原酶抑制可改善糖尿病患者的神经传导速度。
N Engl J Med. 1983 Jan 20;308(3):119-25. doi: 10.1056/NEJM198301203080302.
7
Experimental galactosemia produces diabetic-like retinopathy.实验性半乳糖血症会引发糖尿病样视网膜病变。
Diabetes. 1984 Jan;33(1):97-100. doi: 10.2337/diab.33.1.97.
8
A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy.醛糖还原酶抑制剂索比尼尔治疗慢性疼痛性糖尿病神经病变的对照试验。
Diabetes. 1983 Oct;32(10):938-42. doi: 10.2337/diab.32.10.938.
9
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.用醛糖还原酶抑制剂治疗可逆转实验性糖尿病中轴突运输受损和运动神经传导速度减慢的情况。
Neurosci Lett. 1982 Aug 16;31(2):189-93. doi: 10.1016/0304-3940(82)90115-x.
10
Mechanisms initiating cataract formation. Proctor Lecture.引发白内障形成的机制。普罗克特讲座。
Invest Ophthalmol. 1974 Oct;13(10):713-24.
Zotero 插件